Hostname: page-component-78c5997874-j824f Total loading time: 0 Render date: 2024-11-19T06:28:29.841Z Has data issue: false hasContentIssue false

Effects of Dietary Approaches to Stop Hypertension (DASH) diet on cardiovascular risk factors: a systematic review and meta-analysis

Published online by Cambridge University Press:  15 April 2015

M. Siervo
Affiliation:
Human Nutrition Research Centre, Institute for Ageing and Health, Newcastle University, Biomedical Research Building, Campus for Ageing and Vitality, Newcastle Upon Tyne, NE4 5PL, UK
J. Lara
Affiliation:
Human Nutrition Research Centre, Institute for Ageing and Health, Newcastle University, Biomedical Research Building, Campus for Ageing and Vitality, Newcastle Upon Tyne, NE4 5PL, UK
S. Chowdhury
Affiliation:
Human Nutrition Research Centre, Institute for Ageing and Health, Newcastle University, Biomedical Research Building, Campus for Ageing and Vitality, Newcastle Upon Tyne, NE4 5PL, UK
C Oggioni
Affiliation:
Human Nutrition Research Centre, Institute for Ageing and Health, Newcastle University, Biomedical Research Building, Campus for Ageing and Vitality, Newcastle Upon Tyne, NE4 5PL, UK
D. A. Ashor
Affiliation:
Human Nutrition Research Centre, Institute for Ageing and Health, Newcastle University, Biomedical Research Building, Campus for Ageing and Vitality, Newcastle Upon Tyne, NE4 5PL, UK
J. C. Mathers
Affiliation:
Human Nutrition Research Centre, Institute for Ageing and Health, Newcastle University, Biomedical Research Building, Campus for Ageing and Vitality, Newcastle Upon Tyne, NE4 5PL, UK
Rights & Permissions [Opens in a new window]

Abstract

Type
Abstract
Copyright
Copyright © The Authors 2015 

Background: The Dietary Approach to Stop Hypertension (DASH) is recommended to lower blood pressure (BP) but effects on cardiovascular risk factors are unclear. We conducted a systematic review and meta-analysis of randomised controlled trials (RCTs) to test the effects of the DASH diet on cardiovascular risk factors.

Methods and Results: Medline, EMBASE, and Scopus databases were searched from inception to December 2013. Inclusion criteria were: 1)DASH diet; 2)RCTs; 3)risk factors including systolic and diastolic BP, glucose, high-density lipoproteins (HDL), low-density lipoproteins (LDL), triglycerides and total cholesterol; and 4)control group. Random-effects models were used to determine the pooled effect sizes. Meta-regression analysis examined the associations between the effect size and baseline values of the cardiovascular risk factors, body mass index (BMI), age, quality of trials and study duration.

Results: Twenty articles reporting data for 1,917 participants were included in the meta-analysis. Intervention duration ranged from 2 to 24 weeks. The DASH diet produced significant decreases in systolic (−4·5mmHg, 95%CI = −5·7 −3·2, p < 0·001, Figure 1) and diastolic BP (−2·5mmHg, 95%CI = −3·3 −1·7, p < 0·001) and concentrations of total cholesterol (−7·6 mg/dL, 95%CI = −12·5 −2·8, p = 0·002), LDL (−4·9 mg/dL, 95%CI = −8·9 −0·8, p = 0·01) and glucose (−3·0 mg/dL, 95%CI = −5·5 −0·6, p = 0·01). Changes in both systolic and diastolic BP were greater in participants with higher baseline BP or BMI. These changes in cardiovascular risk factors predicted ~12% reduction in 10-year risk Framingham risk score for cardiovascular diseases (Figure 1).

Fig. 1. Forest-plots of randomized clinical trials investigating the effects of DASH dietary interventions on systolic pressure (BP, left panel) and predicted percent change in 10-year probability of developing a cardiovascular event as a consequence of changes in systolic blood pressure, total cholesterol and HDL from the meta-analysis data (right panel).

Conclusions: The DASH diet improved cardiovascular risk factors and appeared to have greater benefits in subjects at higher cardio-metabolic risk. The DASH diet is an effective nutritional strategy to lower cardiovascular risk.

Figure 0

Fig. 1. Forest-plots of randomized clinical trials investigating the effects of DASH dietary interventions on systolic pressure (BP, left panel) and predicted percent change in 10-year probability of developing a cardiovascular event as a consequence of changes in systolic blood pressure, total cholesterol and HDL from the meta-analysis data (right panel).